1/1
2 files

The Totality of Evidence and Use of ABP 215, a Biosimilar to Bevacizumab

media
posted on 01.12.2020, 10:21 by Jerome Goldschmidt, Vladimir Hanes

Article full text


The above video and summary slide represent the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.


History

Exports